GW1929
Potent and subtype-selective (>1’000-fold) PPARgamma agonist. Angiogenesis inhibitor. Apoptosis inhibitor. Anti-inflammatory. Anti-hyperglycemic and anti-hyperlipidemic agent. Antidiabetic. The glucose-lowering effect in rats is 100-fold more potent than that of troglitazone.
| Catalog Number | AG-CR1-0116-M025 |
| Alternative Name(s) | N-(2-Benzoylphenyl)-L-tyrosine PPARgamma Agonist; (2S)-((2-Benzoylphenyl)amino-3-[4-[2-(methylpyridin-2-ylamino)ethoxy]phenyl]propionic acid |
| Research Area | Apoptosis, Biochemicals, Cancer, Cell Death, Inflammation, Metabolism |
| Molecular Formula | C30H29N3O4 |
| CAS# | 196808-24-9 |
| Purity | >98% |
| Inchi | InChI=1S/C30H29N3O4/c1-33(28-13-7-8-18-31-28)19-20-37-24-16-14-22(15-17-24)21-27(30(35)36)32-26-12-6-5-11-25(26)29(34)23-9-3-2-4-10-23/h2-18,27,32H,19-21H2,1H3,(H,35,36)/t27-/m0/s1 |
| Inchi Key | QTQMRBZOBKYXCG-MHZLTWQESA-N |
| SMILES | COC1=CC(=O)OC(=C1)C1C2(O)CC3OC(=O)[C@]2(O)C(C(=O)C2=CC=CC=C2)C1(O)C3O |
| Size | 25 mg |
| Supplier Page | http://www.adipogen.com/ag-cr1-0116/gw1929.html |